Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Natasha Jacques

Principal pharmacist, specialist services at Heart of England NHS Foundation Trust

Recent stories

  • Type 1 diabetes: insulin managementSubscription

    CP, 2013Comments (2)

    Insulin is used by patients with type 1 diabetes to prevent hyperglycaemia and reduce the risk of developing long-term complications. Different types of insulin have different properties and are used in a range of treatment regimens to best suit each individual patient.

  • Type 1 diabetes: pathophysiology and diagnosis Subscription

    CP, 2013Comments (3)

    Type 1 diabetes is caused by the autoimmune destruction of the insulin-producing b-cells of the islets of Langerhans. Genetic and environmental factors are thought to play a part in the onset of the disease, which usually occurs in childhood and young adulthood.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.